188 related articles for article (PubMed ID: 32341520)
1. Molecular signatures of tumor progression in myxoid liposarcoma identified by N-glycan mass spectrometry imaging.
Heijs B; Holst-Bernal S; de Graaff MA; Briaire-de Bruijn IH; Rodriguez-Girondo M; van de Sande MAJ; Wuhrer M; McDonnell LA; Bovée JVMG
Lab Invest; 2020 Sep; 100(9):1252-1261. PubMed ID: 32341520
[TBL] [Abstract][Full Text] [Related]
2. Deciphering the role of FUS::DDIT3 expression and tumor microenvironment in myxoid liposarcoma development.
Ranji P; Jonasson E; Andersson L; Filges S; Luna Santamaría M; Vannas C; Dolatabadi S; Gustafsson A; Myklebost O; Håkansson J; Fagman H; Landberg G; Åman P; Ståhlberg A
J Transl Med; 2024 Apr; 22(1):389. PubMed ID: 38671504
[TBL] [Abstract][Full Text] [Related]
3. Regulatory mechanisms, expression levels and proliferation effects of the FUS-DDIT3 fusion oncogene in liposarcoma.
Åman P; Dolatabadi S; Svec D; Jonasson E; Safavi S; Andersson D; Grundevik P; Thomsen C; Ståhlberg A
J Pathol; 2016 Apr; 238(5):689-99. PubMed ID: 26865464
[TBL] [Abstract][Full Text] [Related]
4. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
[TBL] [Abstract][Full Text] [Related]
5. Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1-DDIT3 fusion.
Bode-Lesniewska B; Frigerio S; Exner U; Abdou MT; Moch H; Zimmermann DR
Genes Chromosomes Cancer; 2007 Nov; 46(11):961-71. PubMed ID: 17647282
[TBL] [Abstract][Full Text] [Related]
6. The myxoid/round cell liposarcoma fusion oncogene FUS-DDIT3 and the normal DDIT3 induce a liposarcoma phenotype in transfected human fibrosarcoma cells.
Engström K; Willén H; Kåbjörn-Gustafsson C; Andersson C; Olsson M; Göransson M; Järnum S; Olofsson A; Warnhammar E; Aman P
Am J Pathol; 2006 May; 168(5):1642-53. PubMed ID: 16651630
[TBL] [Abstract][Full Text] [Related]
7. Liposarcomas in young patients: a study of 82 cases occurring in patients younger than 22 years of age.
Alaggio R; Coffin CM; Weiss SW; Bridge JA; Issakov J; Oliveira AM; Folpe AL
Am J Surg Pathol; 2009 May; 33(5):645-58. PubMed ID: 19194281
[TBL] [Abstract][Full Text] [Related]
8. Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop.
Andersson MK; Göransson M; Olofsson A; Andersson C; Aman P
BMC Cancer; 2010 Jun; 10():249. PubMed ID: 20515481
[TBL] [Abstract][Full Text] [Related]
9. Identification of inhibitors regulating cell proliferation and FUS-DDIT3 expression in myxoid liposarcoma using combined DNA, mRNA, and protein analyses.
Svec D; Dolatabadi S; Thomsen C; Cordes N; Shannon M; Fitzpatrick P; Landberg G; Åman P; Ståhlberg A
Lab Invest; 2018 Jul; 98(7):957-967. PubMed ID: 29588491
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases.
Antonescu CR; Tschernyavsky SJ; Decuseara R; Leung DH; Woodruff JM; Brennan MF; Bridge JA; Neff JR; Goldblum JR; Ladanyi M
Clin Cancer Res; 2001 Dec; 7(12):3977-87. PubMed ID: 11751490
[TBL] [Abstract][Full Text] [Related]
11. FUS-DDIT3 Fusion Protein-Driven IGF-IR Signaling is a Therapeutic Target in Myxoid Liposarcoma.
Trautmann M; Menzel J; Bertling C; Cyra M; Isfort I; Steinestel K; Elges S; Grünewald I; Altvater B; Rossig C; Fröhling S; Hafner S; Simmet T; Åman P; Wardelmann E; Huss S; Hartmann W
Clin Cancer Res; 2017 Oct; 23(20):6227-6238. PubMed ID: 28637688
[No Abstract] [Full Text] [Related]
12. N-glycan profiling of tissue samples to aid breast cancer subtyping.
Benesova I; Nenutil R; Urminsky A; Lattova E; Uhrik L; Grell P; Kokas FZ; Halamkova J; Zdrahal Z; Vojtesek B; Novotny MV; Hernychova L
Sci Rep; 2024 Jan; 14(1):320. PubMed ID: 38172220
[TBL] [Abstract][Full Text] [Related]
13. The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.
Göransson M; Andersson MK; Forni C; Ståhlberg A; Andersson C; Olofsson A; Mantovani R; Aman P
Oncogene; 2009 Jan; 28(2):270-8. PubMed ID: 18850010
[TBL] [Abstract][Full Text] [Related]
14. Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity.
Willems SM; van Remoortere A; van Zeijl R; Deelder AM; McDonnell LA; Hogendoorn PC
J Pathol; 2010 Dec; 222(4):400-9. PubMed ID: 20839361
[TBL] [Abstract][Full Text] [Related]
15. Multimodal Mass Spectrometry Imaging of N-Glycans and Proteins from the Same Tissue Section.
Heijs B; Holst S; Briaire-de Bruijn IH; van Pelt GW; de Ru AH; van Veelen PA; Drake RR; Mehta AS; Mesker WE; Tollenaar RA; Bovée JV; Wuhrer M; McDonnell LA
Anal Chem; 2016 Aug; 88(15):7745-53. PubMed ID: 27373711
[TBL] [Abstract][Full Text] [Related]
16. Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry.
Ritchie G; Harvey DJ; Stroeher U; Feldmann F; Feldmann H; Wahl-Jensen V; Royle L; Dwek RA; Rudd PM
Rapid Commun Mass Spectrom; 2010 Mar; 24(5):571-85. PubMed ID: 20131323
[TBL] [Abstract][Full Text] [Related]
17. Paratesticular myxoid/round cell liposarcoma harboring type 3 DDIT3-FUS fusion gene: report of a very rare case.
Zozumi M; Nakai M; Matsuda I; Hao H; Tsukamoto Y; Shiraishi Y; Nojima M; Yamamoto S; Hirota S
Pathol Res Pract; 2013 Feb; 209(2):124-7. PubMed ID: 23276404
[TBL] [Abstract][Full Text] [Related]
18. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis.
de Vreeze RS; de Jong D; Tielen IH; Ruijter HJ; Nederlof PM; Haas RL; van Coevorden F
Mod Pathol; 2009 Feb; 22(2):223-31. PubMed ID: 18820664
[TBL] [Abstract][Full Text] [Related]
19. A Low-Grade Myxoid Liposarcoma Arising in a Deep-Seated Conventional Lipoma.
Tsagkozis P; Haglund F
Int J Surg Pathol; 2019 Dec; 27(8):919-922. PubMed ID: 31218893
[TBL] [Abstract][Full Text] [Related]
20. Establishment and characterization of a new human myxoid liposarcoma cell line (DL-221) with the FUS-DDIT3 translocation.
de Graaff MA; Yu JS; Beird HC; Ingram DR; Nguyen T; Juehui Liu J; Bolshakov S; Szuhai K; Åman P; Torres KE; Lev D; Nielsen TO; Bovée JV; Lazar AJ; Somaiah N
Lab Invest; 2016 Aug; 96(8):885-94. PubMed ID: 27270875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
